Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy - Test2 - elhamkhani - TriplyDB

Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy

Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy

http://www.wikidata.org/entity/Q28544949

about

How to Define the Latent Reservoir: Tools of the Trade Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases Epigenetic control of HIV-1 post integration latency: implications for therapy Impact of Chromatin on HIV Replication CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence research Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents Achieving HIV-1 Control through RNA-Directed Gene Regulation Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation Latency reversal and viral clearance to cure HIV-1.A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.Romidepsin-induced HIV-1 viremia during effective ART contains identical viral sequences with few deleterious mutations.Advancements in Developing Strategies for Sterilizing and Functional HIV Cures.High-throughput Characterization of HIV-1 Reservoir Reactivation Using a Single-Cell-in-Droplet PCR Assay.The Human Immunodeficiency Virus 1 ASP RNA promotes viral latency by recruiting the Polycomb Repressor Complex 2 and promoting nucleosome assembly Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapy.Experiences and expectations of participants completing an HIV cure focused clinical trial.Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment.HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV Remission.Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo Hydrogen Peroxide Induce Human Cytomegalovirus Replication through the Activation of p38-MAPK Signaling Pathway.Modeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected Cells.Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma.The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.H3K27 Demethylation at the Proviral Promoter Sensitizes Latent HIV to the Effects of Vorinostat in Ex Vivo Cultures of Resting CD4+ T Cells.Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors.HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.Leveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future Directions Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function.HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs.A Novel Class of HIV-1 Antiviral Agents Targeting HIV via a SUMOylation-Dependent Mechanism.The effect of Ingenol-B on the suppressive capacity of elite suppressor HIV-specific CD8+ T cells.Paediatric HIV infection in the 'omics era: defining transcriptional signatures of viral control and vaccine responses.

P2860

Q26766705-0AFF99A6-3309-4D67-B6FE-16F1CC236B79 Q26768497-7E6497CC-AAAE-4BFF-8E78-AD7CA50E14F2 Q26781191-6CEB3329-BBD3-4B60-897F-EB6E124F5B21 Q26782046-E267C2C4-EA0A-4E24-9379-4366749EE8AF Q26801498-834B74D7-66AD-4690-A58B-795EFE56C38B Q27312050-B632CF8A-6CB7-4B83-80EB-21940C5C4B30 Q28077662-55859354-7004-439C-961D-6BE49C559E8B Q28079455-C2412151-EBB5-425C-85B1-EA6DDEF92221 Q28080090-EC6EEC08-1317-4581-9E30-561591C4EB09 Q28546901-F6F9091C-F0F6-470A-B6EE-067A4846C250 Q30248766-D25CEF5E-F7FD-4798-8B71-C7C36A8107B2 Q30385378-19FA753D-C723-4369-873A-6DA5FA23C852 Q30490742-73D92EB9-7620-406F-987D-35CCF816D695 Q33654409-717CEACB-E281-4452-9BF0-395FBF9E8E8A Q33817708-2213F372-742F-49DA-81A3-88FC69F7D7BD Q33893725-F850EBE3-D3D5-463E-AF42-1DC842EA0FF1 Q35436367-BBCA5867-6D78-4EE1-91C2-625845A101B0 Q35471789-B70CBF80-DB70-4EB1-B60E-9823AD25DA2D Q35652578-2D066C85-9C75-4F21-BE3A-F9E2BD083F6D Q35680431-1FDE891A-E3FD-4D99-8630-1FE26B5992C7 Q35720063-088B73B6-3039-4040-8DB9-C174C1DE241C Q35778783-65338791-52DC-4AB7-AA0B-76DF75996A21 Q35808633-1461B58A-B50E-489E-B7AE-BFD8FE92C593 Q35819184-340D9B75-8070-4B6D-9AEE-661683F429E4 Q35822484-F19F8A84-9B09-4C88-B4D6-7D1A4A48CC2F Q35829282-CC11546D-C77C-44AA-B03C-F7A17D53E8DD Q35914266-6027319F-3B6B-4822-9CA3-85175EDCD25C Q35942658-D39F1D8F-8B3D-4DE1-A081-76CE1FDF3405 Q35973632-B25697D9-2FB6-477C-A40F-AC2C769CBD5A Q36030989-46784277-23CC-4F55-890A-9326F24647D7 Q36037844-C0EFB581-19F1-408D-AE2B-00AA10712669 Q36076018-11D012EB-D37A-49D7-8483-31AB45E66249 Q36080200-97ED5DC1-9574-4E3E-BB23-6311ECDCC6B5 Q36086345-37683C5A-105F-4EDA-959D-36A808A20AAD Q36104946-6C781C8C-4551-4C5E-817F-E6B0D36810A3 Q36121883-A6D444E6-EFF0-46C5-9440-AF6DA8000AC1 Q36311695-54134A11-768C-4DDE-987B-D337613358B8 Q36353497-3790BC87-AB9C-4C7B-A136-3E70169D7BB6 Q36361960-78F3A001-AB57-41BA-81C4-439F10CC1FA7 Q36487031-6BD426C2-2880-4FFB-B08D-AAF407012AFD

P2860

Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy

http://www.wikidata.org/entity/Q28544949

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Activation of HIV transcriptio ...... ressive antiretroviral therapy

@ast

Activation of HIV transcriptio ...... ressive antiretroviral therapy

@en

Activation of HIV transcriptio ...... ressive antiretroviral therapy

@nl

type

label

Activation of HIV transcriptio ...... ressive antiretroviral therapy

@ast

Activation of HIV transcriptio ...... ressive antiretroviral therapy

@en

Activation of HIV transcriptio ...... ressive antiretroviral therapy

@nl

prefLabel

Activation of HIV transcriptio ...... ressive antiretroviral therapy

@ast

Activation of HIV transcriptio ...... ressive antiretroviral therapy

@en

Activation of HIV transcriptio ...... ressive antiretroviral therapy

@nl

P1433

Q28544949-4BB61F95-29D8-4987-845F-08780ACF1996

P1476

Q28544949-C8D71E39-73C5-4A37-A63F-F24183C598CC

P2093

Q28544949-026569C0-10CB-45A1-95EB-ADFFAB9B8EEB

Q28544949-0CA41FE1-0704-4637-9F22-6926DDAD4778

Q28544949-0D597EA0-598B-42FF-9028-E15D35091031

Q28544949-1681E3CE-AF23-4606-8301-C999960F63D4

Q28544949-19B0FDF3-A067-4721-8D9A-317430798DD6

Q28544949-22E6AA5B-09EA-48DC-8173-44909EF79843

Q28544949-22E82B72-0F7A-4931-B9E8-4640DE5FEF35

Q28544949-3A266E21-A81A-470A-92C0-A16E45579C37

Q28544949-48FF7999-1ACC-4D30-8AA5-6D33DC5759C4

Q28544949-4F0F8214-F5A5-44F3-801B-963993E9C053

P2860

Q28544949-00E976EB-D11C-443A-8614-54E7385761CE

Q28544949-03BFD4E7-DC53-47BD-B5FE-8C6A0233C01E

Q28544949-0586933D-A9E4-492C-BF75-7FB93537F06F

Q28544949-0759EEE7-5BC2-4B11-A86B-FDD7A1423EF3

Q28544949-0D0CC637-3142-449D-B615-9BC6C1C2A1BC

Q28544949-10BF8062-97B9-47F2-8CA2-716E80F8B385

Q28544949-160A7844-6FD8-4442-BB0F-6B96B0B4D054

Q28544949-2444DA08-C210-47AD-8C1E-2D9CCCAC3F98

Q28544949-2A42973F-E3A5-4AB4-870E-A7C0CC5A7632

Q28544949-2FD8C3DD-94A1-44C2-AA63-EBD7CD009521

P304

Q28544949-D6F1DE8E-3557-4781-8CB2-9D2909B454FA

P31

Q28544949-BF81B63A-3A0E-4F2D-B310-5D408F10A587

P3181

Q28544949-7FFA2633-5438-4A91-9110-93A1015D150C

P356

Q28544949-98D4FDC4-87B0-430B-83ED-161C82EF158D

P407

Q28544949-0987964F-4961-4DB0-993C-67AA4DA7EAE1

P433

Q28544949-8BD2335E-076A-455B-A63E-43495E5CBBDD

P478

Q28544949-42174E9C-7CEE-42C4-991C-373F9A476B3E

P50

Q28544949-1EE3FBDF-4EB3-4CAD-BA5F-1D256E834BAA

Q28544949-1F55E4BB-D98A-4A22-A0B6-054B29DFCDFB

Q28544949-2EE6DA9C-3E48-410A-B419-8755573A3D4B

Q28544949-34B850A1-05E8-47F3-92BA-52888D9AFE54

Q28544949-3D61A1DF-56A3-42B5-BED1-4A68F4F46BB9

Q28544949-46C72EDE-61C4-4E05-A3FF-82B6EFA3A420

Q28544949-9128FDE4-726B-4706-8951-A64D3A8C039F

Q28544949-AC0CDBB7-B7EE-40CF-8343-A0F460FCDF9E

P577

Q28544949-98F45C25-12F4-4F44-803F-83223E7FA69D

P5875

Q28544949-2F46AC28-45A7-4998-BD7E-EB482C798B28

P698

Q28544949-31ABF887-BCC5-4FA9-8F6F-EE06C45FD344

P921

Q28544949-0D9B521A-91B9-4F1F-84B5-FB799CEB4D02

Q28544949-D0F397B8-22DE-4834-AC60-3DBEC75326C8

P932

Q28544949-62541839-391D-40BC-8904-DD4E72CC571A

P3181

P356

JOURNAL.PPAT.1004473

P1433

P1476

Activation of HIV transcriptio ...... ressive antiretroviral therapy

@en

P2093

Ajantha Solomon

http://www.w3.org/2001/XMLSchema#string

Ben P Martin

http://www.w3.org/2001/XMLSchema#string

Daria J Hazuda

http://www.w3.org/2001/XMLSchema#string

Elizabeth Sinclair

http://www.w3.org/2001/XMLSchema#string

Francesco A Procopio

http://www.w3.org/2001/XMLSchema#string

Gregor Brown

http://www.w3.org/2001/XMLSchema#string

Janine Roney

http://www.w3.org/2001/XMLSchema#string

Jeffrey Ahlers

http://www.w3.org/2001/XMLSchema#string

Jo Watson

http://www.w3.org/2001/XMLSchema#string

Joumana Zeidan

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Diverse functions of PHD fingers of the MLL/KMT2 subfamily

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing.

An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence.

Inhibition of early steps of HIV-1 replication by SNF5/Ini1.

P304

e1004473

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1098167

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PPAT.1004473

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Sharon R. Lewin

Miranda Z. Smith

Ricky W Johnstone

Nicolas Chomont

James H McMahon

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268234128

http://www.w3.org/2001/XMLSchema#string

P698

25393648

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

4231123

http://www.w3.org/2001/XMLSchema#string